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Abstract. - BACKGROUND: Hemophagocyt-
ic lymphohistiocytosis (HLH) is a rare syn-
drome that is often fatal despite treatment. It is
caused by a dysregulation in natural killer T-cell
function, resulting in activation and prolifera-
tion of histiocytes with uncontrolled hemo-
phagocytosis and cytokines overproduction.
The syndrome is characterized by fever, he-
patosplenomegaly, cytopenias, liver dysfunc-
tion, and hyperferritinemia. HLH can be either
primary, with a genetic aetiology, or secondary,
associated with malignancies, autoimmune dis-
eases, or infections. 
AIM: To focus on secondary HLH complicat-
ing zoonotic diseases. 
MATERIALS AND METHODS: PubMed search
of human cases of HLH occurring during
zoonotic diseases was performed combining the
terms (haemophagocytic OR haemophagocyto-
sis OR hemophagocytosis OR hemophagocytic
OR erythrophagocytosis OR macrophage activa-
tion syndrome) with each one of the etiological
agents of zoonoses.
RESULTS: Among bacterial diseases, most pa-
pers reported cases occurring during brucel-
losis, rickettsial diseases and Q fever. Regarding
viral diseases, most of the cases were reported
in patients with avian influenza A subtype
H5N1. Among the protozoan zoonoses, most of
the cases were reported in patients with viscer-
al leishmaniasis. Regarding zoonotic fungi,
most of the cases were reported in AIDS patient
with histoplasmosis. No cases of secondary
HLH were reported in patient with zoonotic
helminthes.
CONCLUSIONS: Zoonotic diseases are an im-
portant cause of HLH. Secondary HLH can delay
the correct diagnosis of the zoonotic disease,
and can contribute to an adverse outcome.
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Introduction
Although zoonotic infections are a major bur-
den worldwide – both in terms of immediate and
long-term morbidity and mortality1,2 and in terms
of socioeconomical, ecological, and political im-
pact3 – scientific and public health interest and
funding for these diseases remain relatively minor
and inadequate4. In the present review we will fo-
cus on secondary hemophagocytic lymphohistio-
cytosis (HLH) complicating zoonotic diseases. 
HLH is a potentially fatal hyperinflammatory
syndrome that is characterized by histiocyte prolif-
eration and hemophagocytosis. HLH may be in-
herited (primary, familial) and occurs generally in
infants or may be secondary to infection, malig-
nancy or rheumatologic conditions, thereby, oc-
curring at any age. The former is a syndrome asso-
ciated with autosomal recessive disorders that lead
to defects in apoptosis induction of virus-infected
cells or tumor cells by cytolytic immune cells, in-
cluding natural killer (NK) cells or cytotoxic T
lymphocytes (CTL). Defects of cytotoxic activities
of NK or CTL cells, X-linked lymphoproliferative
syndrome type 1 (XLP1) and type 2 (XLP2) can
also lead to HLH development5. Secondary HLH,
called also macrophage activation syndrome
(MAS), is a common finding in systemic juvenile
idiopathic arthritis (sJIA) in which, an apparent
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combining the terms (haemophagocytic, or
haemophagocytosis, or hemophagocytosis, or
hemophagocytic, or erythrophagocytosis, or
macrophage activation syndrome) with each one
of the etiological agents of zoonoses and/or one
of the diseases indicated in Tables II and III for
the period January 1950 to August 2012. A study
was considered eligible for inclusion in the sys-
tematic review if it reported data on patients
with zoonotic diseases who had microscopic
signs of hemophagocytosis and/or fulfilled the
diagnostic criteria of the HLH Study Group of
the Histiocyte Society.
Results
The PubMed search identified 1157 papers. Du-
plicate publications or papers not reporting clini-
cal cases were excluded. After a scrupulous analy-
sis, 153 papers were further evaluated. In the Table
hybrid situation is present. In fact, several muta-
tions have been reported recently in sJIA6. Thus,
as in other infection-associated hyperinflammato-
ry syndromes7-10, activation of receptors and cells
of the innate immunity system is likely to play a
major role in HLH.
The most typical presenting signs and symp-
toms are fever, hepatosplenomegaly, and cytope-
nias. Less frequently observed clinical findings
are neurological symptoms, lymphadenopathy,
edema, skin rash, and jaundice11,12. Common lab-
oratory findings include hypertriglyceridemia,
hyperferritinemia, a coagulopathy with hypofib-
rinogemia, and elevated aminotransferases11,12.
However, HLH is diagnosed using clinical crite-
ria developed by the HLH Study Group of the
Histiocyte Society13,14 (Table I).
Literature Review
PubMed search of human cases of HLH oc-
curring during zoonotic diseases was performed
The diagnosis of HLH can be established if one of either 1 or 2 below is fulfilled:
1. A molecular diagnosis consistent with HLH
2. Diagnostic criteria for HLH are fulfilled (five out of the eight criteria below):
• Fever
• Splenomegaly
• Cytopenias (affecting ≥ 2 lineages in the peripheral blood):
Hemoglobin < 90 g/l (in infants < 4 weeks: hemoglobin < 100 g/l
Platelets < 100.000/ml
Neutrophils < 1000/ml
• Hypertriglyceridemia and/or hypofibrinogenemia:
Fasting triglycerides ≥ 265 mg/dl
Fibrinogen ≤ 1.5 g/L
• Hemophagocytosis in bone marrow or spleen or lymphnodes
• Low or absent NK-cell activity
• Ferritin ≥ 500 µg/l
• Soluble CD25 ≥ 2400 U/L
Comments:
(1) If hemophagocytic activity is not proven at the time of presentation, further search for hemophagocytic activity is en-
couraged. If the bone marrow specimen is not conclusive, material may be obtained from other organs. Serial marrow
aspirates over time may also be helpful.
(2) The following findings may provide strong supportive evidence for the diagnosis: (a) spinal fluid pleocytosis
(mononuclear cells) and/or elevated spinal fluid protein, (b) histological picture in the liver resembling chronic per-
sistent hepatitis (biopsy). 
(1) Other abnormal clinical and laboratory findings consistent with the diagnosis are: cerebromeningeal symptoms,
lymph node enlargement, jaundice, edema, skin rash. Hepatic enzyme abnormalities, hypoproteinemia, hyponatrem-
ia, VLDL ↑, HDL ↓.
Table I. HLH 2004 Diagnostic criteria (modified from ref.13,14).
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Bacteria References and notes
Anaplasma 15Review
phagocytophilum
Bartonella sp. 16Renal transplant recipients
Borrelia sp. 17Lyme disease
Brucella sp. 18Analysis of children with brucellosis associated with pancytopenia, Turkey; 198 year-old male,
Turkey; 2084 year-old female, antilymphoma chemotherapy; 21Multicenter retrospective study,
Turkey; 22Retrospective study, 3 patients, Turkey; 2311 year-old boy, Turkey;
245 patients, Spain; 25,26disseminated intravascular coagulation, Spain; 27,28; Retrospective study, Saudi
Arabia; 29,30Two and half years old female, India; 31Pulmonary involvement, Iran; 32Bone marrow
biopsy findings in brucellosis patients with hematologic abnormalities, China; 
Campylobacter sp. 33Campylobacter fetus, AIDS, USA
Capnocytophaga sp 34Sudden Sensorineural Hearing Loss, Japan
Clostridium sp. 35AIDS; 36Pancreatic carcinoma 
Coxiella burnetii 37,38,39,37,38,40
Ehrlichia chaffeensis 41Two children, USA; 42Case report, USA; 43Fatal case, USA; 4467 year-old white man, disseminated
and Ehrlichia intravascular coagulopathy, USA
ewingii
Leptospira sp. India 45,46Fatal case, Taiwan:
Listeria sp. 47L. monocytogenes, bone marrow transplant recipient, France




Rickettsia spp 54Murine typhus in returned travelers; 55MSF, Italy; 52,56Rickettsia conorii; 57MSF; 58MSF, Israel;
59Fulminant Rocky Mountain spotted fever
Salmonella sp. 60Child suffering from chronic granulomatous disease, associated with septicemia due to Salmonella





Hantaviruses 69Hemorrhagic fever with renal syndrome, South Korea. 70Hemorrhagic fever with renal syndrome
Hepatitis E virus 71Japan.
Influenza viruses 72-77influenza A virus H5N1 subtype; 78Fatal case of swine influenza virus in an immunocompetent
host, USA
SARS coronavirus 79-82China, Taiwan
Protozoa
Babesia sp. 83-85Splenectomized renal allograft recipient, USA
Leishmania spp. 86Children with HLH treated at the University Children’s Hospital in Belgrade; 87-89Chronic granulo-
matous disease; 90Four childhood cases; China; 91immunocompetent adult-case report and review; 92A
review of situation in Thailand; 93Retrospective study Clinical analysis on 28 patients with hemo-
phagocytic lymphohistiocytosis syndrome, China; 
94 Two cases, India; 95AIDS, India; 9628 years man, India; 979 cases, India; 98Illustrative case and re-
view, India; 99Fatal case, India; 100Retrospective study, India; 101Cerebrospinal fluid involvement,
Oman; 102Nine cases, Saudi Arabia.
1034.5 month-old infant associated with H1N1 virus infection, Turkey; 104Adolescent, Turkey; 105
Child, Turkey; 106Child; Turkey; 1074 year-old boy travel history, Turkey; 1085 year-old boy, Turkey;
10918 Turkish children (2 weeks-72 months); 110Child, pseudomonas septicemia, myelodysplasia,
Turkey 111Greece; 112 Epstein Barr, Cyprus;
1132 year-old child, Israel; 11446 year-old woman, Israel;
Table II. Clinical significant agents of zoonoses found associated with secondary HLH.
Table continue
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II are reported all the agents of zoonoses associat-
ed with secondary HLH, while in the second col-
umn of Table III are listed zoonotic agents not as-
sociated with secondary HLH.
Among bacterial diseases, 15 papers reported
cases occurring during brucellosis, 16 during
rickettsial diseases (Rickettsia spp, Orientia sp,
Erlichia spp and Anaplasma spp), 6 during Q
Bacteria References and notes
Protozoa
Leishmania spp. 11520 month-old boy, Tunisia; 1162 year-old boy, Tunisia; 117 Tunisia; 118 2 severe cases, Tunisia;
11915 month-old girl, Travel Spain, Norway; 1207 year-old previously healthy Czech boy, travel in Italy; 
12116 month-old girl, Spain; 122Spain; 123Spain; 124Spain; 125Pericardial effusion, Spain; 126Rheumatoid
arthritis, adalimumab, Spain; 127steroid, bronchial asthma, Spain; 128France; 129France; 13012 month-
old girl, France; 13112 cases, France
Toxoplasma gondii 132,133Primary disseminated toxoplasmosis;
134,16,135renal transplantation; 136Bone marrow transplantation;
137,138,139AIDS
Fungi
Cryptococcus 140A child case, cryptococcal meningoencephalitis, Japan
neoformans
Histoplasma 139, 141-149AIDS; 150AIDS Reconstitution inflammatory syndrome; 
capsulatum 151Pediatric AIDS
152,153Leukemia; 15421-year-old man with Still’s disease; 155,156Adult-onset Still’s disease, adalimumab,
157Kidney transplant recipients, USA; 158Heart transplant recipient, USA; 1596 year-old boy with
chronic mucocutaneous candidiasis, USA; 160Sarcoidosis on chronic steroid treatment, USA;
161France; 162Immunocompetent, India; 1632 cases, India; 
164Fungal endocarditis, chronic hepatitis C, cryoglobulinemia, renal failure and Staphylococcus au-
reus perinephric abscess and bacteremia
Penicillium 165AIDS, China; 166AIDS, Thailand; 167Thailand; 168China
marneffei
Table II. (Continued). Clinical significant agents of zoonoses found associated with secondary HLH.
Bacteria Bacillus antraci, Chlamydophyla psittaci, Corynebacterium ulcerans, Escherichia coli O157H7,
Francisella tularensis, Helicobacter sp, Mycobacterium bovis, Mycobacterium caprae, Mycobac-
terium marinum, Mycobacterium microti, Mycobacterium ulcerans, Mycobacterium genavense,
Mycobacterium malmoense, and Mycobacterium farcinogenes, Pasteurella sp. Shigella sp., Staphy-
lococcus aureus (clearly associated to animal reservoir), Streptococcus suis, Streptococcus equi,
Streptococcus canis, Streptococcus acidominimus, Streptococcus bovis,, Vibrio sp. (excluding Vib-
rio colera), Yersinia sp.
Viruses Borna disease virus, California serogroup viruses, Chikungunya virus, Cowpox virus, Ebola virus,
Hendra virus, Japanese encephalitis virus, Kyasanur forest disease virus, Lassa virus, Lymphocytic
choriomeningitis virus, Marburg virus, Monkeypox virus, Nipah virus, Omsk haemorrhagic fever
virus, Oropouche virus, Rabies and lyssaviruses, Rift Valley fever virus, Ross River virus, Sindbis
virus, Tick-borne encephalitis, Venezuelan equine encephalitis virus, West Nile virus, Yellow fever
virus, Zika virus
Protozoa Balantidium coli, Blastocystis hominis, Cryptosporidium parvum, Giardia lamblia, Plasmodium
knowlesi, Trypanosoma brucei, Trypanosoma cruzi
Fungi Basidiobolus rana rum, Malasezia spp., Microsporum spp., Paracoccidioides brasiliensis, Trichophyton
spp.
Helminths Ancylostoma spp., Angiostrongylus spp., Clonorchis sinensis and Opisthorchis spp., Diphylloboth-
rium spp, Dirofilaria spp., Echinococcus spp., Echinococcus spp., Fasciola spp., Fasciolopsis bus-
ki, Gnathostoma spp., Paragonimus spp., Thelazia spp., Toxocara spp., Trichinella spp.
Table III. Bacterial, viral, fungal and helminthic agents of zoonoses not associated with secondary HLH.
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fever, 2 during leptospirosis. One paper each re-
ported papers during Lyme disease or Capnocy-
tophaga sp. infection. Most of the above papers
described cases of secondary HLH occurring in
immunocompetent patients without important co-
morbidities. Cases of Bartonella, Clostridium,
Listeria, Mycobacterium, Salmonella spp and
Campylobacter fetus infections were less report-
ed and most of them occurred in patients with
major comorbidities. Among the zoonotic my-
cobacterial diseases, HLH was reported only in
patients with Mycobacterium avium infection af-
fected by HIV infection or by systemic lupus
erythematosus.
Among viral diseases, cases were reported in
patients with avian influenza A subtype H5N1,
swine influenza, SARS coronavirus, Crimean–
Congo haemorrhagic fever, hepatitis E virus.
Most of cases occurred in immunocompetent pa-
tients without important comorbidities.
Regarding the protozoan zoonoses, most of the
cases were reported in patients with visceral
leishmaniasis. Only in few cases of the 46 arti-
cles reporting such cases, comorbidities were
present. Nine papers reported cases occurring in
patients with toxoplasmosis and most of them
were immunocompromised. Two cases were re-
ported in patient with babesiosis.
Regarding zoonotic fungi, 23, four and one pa-
per reported cases occurring in patients with
Histoplasma capsulatum, Penicillium marneffei
and Cryptococcus neoformans infections, respec-
tively. Most of them occurred in immunocompro-
mised patients. No cases of secondary HLH were
reported in patient with zoonotic helminths.
In one case each, a double infection with Ep-
stein Barr virus112, H1N1 virus103, Pseudomonas
septicemia,110 and Staphylococcus aureus per-
inephric abscess164, in addition to the zoonotic
agent, were reported.
Regarding comorbidities, five papers reported
cases occurring in kidney transplant recipi-
ents16,134,135,157, one in a heart transplant recipi-
ent158 and two in bone marrow transplant recipi-
ents47,136. Twenty papers reported cases occurring
in HIV-infected patients33,48,95,137-139,141-151,165,166; of
them, one occurred in a pediatric patient165, and
one in the course of AIDS Reconstitution Inflam-
matory Syndrome150. In two and four papers
leukaemia152,153 and chronic granulomatous dis-
ease (CGD)60,87-89, respectively, were present. Oth-
er major comorbidities reported were rheumato-
logic diseases49,126,154-156, which in three cases
were under treatment with adalimumab126,155,156.
Other major comorbidities/immunosuppressive
conditions were chronic steroid treatment127,160,
chronic mucocutaneous candidiasis159, antilym-
phoma chemotherapy20, and pancreatic carcino-
ma36. Five papers reported cases occurring after
travel to endemic zones54,80,107,119,169. 
Discussion
Zoonotic infections are defined, in general, as
infections transmitted from animal to man (and
less frequently vice versa), either directly (through
direct contact or contact with animal products) or
indirectly (through an intermediate vector as an
arthropod or an insect)170. The main zoonotic fea-
tures of influenza are represented by the role of
animal hosts as reservoirs and substrates for the
development of novel strains, and their role in the
introduction of these strains into human pathology.
Avian H5N1 influenza is a typical zoonotic infec-
tion, requiring close contact with infected animal
hosts1. The current H1N1 pandemic strain stopped
being zoonotic after human-to-human transmis-
sion emerged as the cause of the pandemic. The
single non-human hosts for each of influenza B
and influenza C viruses play a minimal role in hu-
man disease1. Avian influenza A subtype H5N1 in-
fection and severe acute respiratory syndrome
(SARS) due to coronavirus (SARS-CoV) share
similar pathologic features. Pneumocytes are the
primary target of infection, resulting in diffuse
alveolar damage. Systemic cytokine activation re-
sults in hemophagocytic syndrome, lymphoid de-
pletion, and skeletal muscle fiber necrosis171.
However, HLH has also been found in fatal cases
of H1N1 infection during the pandemic which
emerged in April 2009172.
HIV infection alone or in the presence of other
opportunistic and non-opportunistic infections or
malignancies has been associated with HLH, and
HLH has also been described in the setting of
immune reconstitution inflammatory syn-
drome150,173,174. 
Also rotavirus infection can cause secondary
HLH175, but this is not a frequent finding176-180. Of
note, animal rotaviruses might be able to cross
species barriers, and lack of systematic surveil-
lance of rotavirus infection in small animals hin-
ders the ability to establish firm epidemiological
connections178,180-182.
Almost all the cases associated with bacterial
infections were due intracellular organisms fre-
quently causing epatosplenomegaly and leukope-
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agnosis of the zoonotic disease, and can con-
tribute to an adverse outcome. Further studies are
needed to understand whether an immunosup-
pressive treatment could be beneficial in those
cases that do not promptly respond to anti-infec-
tive therapy.
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